Google

Saturday, June 30, 2012

Bristol-Myers to Buy Diabetes Maker Amylin for $5.3 Billion - Bloomberg

Bristol-Myers to Buy Diabetes Maker Amylin for $5.3 Billion - Bloomberg

No comments:

Post a Comment